Medtronic Stock Forecast

Stock Price Forecast

According to 29 analysts polled by S&P Global, Medtronic stock has a consensus rating of "Buy" and an average price target of $97.84. The average 1-year stock price forecast is 17.60% higher than the current stock price, while the lowest is $78 (-6.25%) and the highest is $121 (+45.43%).

Price Target: $97.84 (+17.60%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$78	$97.84	$100	$121
Change	-6.25%	+17.60%	+20.19%	+45.43%

Analyst Ratings

The average analyst rating for Medtronic stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	14	14	14	15	15	15
Buy	5	4	4	2	3	3
Hold	13	13	12	13	12	12
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	32	31	30	30	30	30

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Shagun Singh Chadha RBC Capital	RBC Capital	Buy Maintains $118	Buy	Maintains	$118	+41.83%	Jul 14, 2026
Matthew O'Brien Piper Sandler	Piper Sandler	Hold Reiterates $85	Hold	Reiterates	$85	+2.16%	Jul 14, 2026
Ryan Zimmerman BTIG	BTIG	Buy Reiterates $90 → $91	Buy	Reiterates	$90 → $91	+9.37%	Jul 13, 2026
Travis Steed Bank of America Securities	Bank of America Securities	Buy Maintains $95	Buy	Maintains	$95	+14.18%	Jul 13, 2026
Mike Kratky Leerink Partners	Leerink Partners	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jul 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

38.83B

from 36.36B

6.79%

from 36.36B

Revenue Next Year

40.19B

from 38.83B

3.49%

from 38.83B

EPS This Year

5.95

from 5.53

7.56%

from 5.53

EPS Next Year

6.40

from 5.95

7.69%

from 5.95

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Apr 29, 2022	Apr 28, 2023	Apr 26, 2024	Apr 25, 2025	Apr 24, 2026	Apr 30, 2027
Revenue	31.69B	31.23B	32.36B	33.54B	36.36B	38.83B
Revenue Growth	5.21%	-1.45%	3.64%	3.62%	8.43%	6.79%
Gross Profit	21.66B	20.61B	21.27B	21.93B	23.75B	25.29B
Gross Margin	68.35%	65.98%	65.73%	65.39%	65.31%	65.13%
Operating Income	6.85B	5.57B	6.83B	6.33B	7.27B	9.72B
Net Income	5.04B	3.76B	3.68B	4.66B	4.80B	5.58B
EPS	-	-	-	-	5.53	5.95
EPS Growth	-	-	-	-	0.73%	7.56%
Forward PE	18.03	17.32	14.87	14.64	14.29	13.99
Dividend / Share	2.52	2.72	2.76	2.80	2.84	2.97
Dividend Growth	-	7.94%	1.47%	1.45%	1.43%	4.69%
Free Cash Flow	-1.16B	10.06B	5.72B	4.16B	4.63B	6.30B
No. Analysts	-	-	-	-	-	28

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	39.0B
Avg	38.8B
Low	38.0B

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	7.3%
Avg	6.8%
Low	4.6%

EPS Forecast

Chart

EPS	2027	2028	2029
High	6.02
Avg	5.95
Low	5.88

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	8.9%
Avg	7.6%
Low	6.3%